SPIMACO’s Moroccan plant to begin trial run in Q4 2019

25/03/2019 Argaam

 

Saudi Pharmaceutical Industries and Medical Appliances (SPIMACO) expects pilot operations at Morocco’s facility to commence in the fourth quarter of the year.

 

Electrical and mechanical construction services at the Casablanca-based pharmaceutical plant were completed, SPIMACO said in a bourse statement on Monday.

 

However, the qualification process was rescheduled to begin in Q3 2019, due to a delay in receiving the required equipment.

 

The related financial impact will be announced later on, the pharmaceutical producer added.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.